Valeritas Holdings, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Valeritas Holdings, Inc. | VLRX - |
Last Trade $1.08 |
$0.00 |
$0.00 | 37.6 million | |
Oppenheimer & Co., BTIG
|
Co-Manager(s): National Securities |
|
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Valeritas Holdings, Inc., and our comprehensive analysis, click "Buy Market Research".
About Valeritas Holdings, Inc. (adapted from Valeritas Holdings, Inc. prospectus):
They are a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas flagship product, V-Go Wearable Insulin Delivery device, is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VLRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved